Research reveals acridine-based hybrids show promising antiproliferative activity against cancer, suggesting new treatment options.
No takes yet. Share an insight, caveat, or question.
Gallala et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: